UK and EU- How do pharmaceutical companies justify the high level of spending on political lobbying in Europe and the UK?
Pharmaceutical companies justify their significant spending on political lobbying by arguing that it is a necessary and legitimate part of operating in a highly regulated industry. Their core arguments center on the need to protect intellectual property, ensure a competitive market, and promote policies that incentivize research and development (R&D) to bring new, life-saving medicines to...
0 Commentarii 0 Distribuiri 860 Views 0 previzualizare
Sponsor
Sponsor
Sponsor
google-site-verification: google037b30823fc02426.html